-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$35.00101.27% Upside
Pacira BioSciences, Inc. Frequently Asked Questions
-
What analysts cover Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. has been rated by research analysts at Piper Sandler, Jefferies, Truist Financial, H.C. Wainwright, BMO Capital, Needham in the past 90 days.